As diabetes care continues to be a major focus, new treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a exciting generation in GLP-1 receptor agonist medications. While all aim to https://semaglutide418636.toki-blog.com/728737/the-new-drug-vs-tirzepatide-vs-semaglutide-a-head-to-head-analysis